Home › Funds › ACT CAPITAL MANAGEMENT, LLC › RGNX

ACT CAPITAL MANAGEMENT, LLC position in RGNX

REGENXBIO INC · Health Care

ACT CAPITAL MANAGEMENT, LLC reported holding 67,500 shares of RGNX (REGENXBIO INC) in its Q2 2026 13F filing — a position valued at US$809K, representing 0.53% of its reported portfolio and ranking #31 among its reported holdings. ACT CAPITAL MANAGEMENT, LLC has disclosed RGNX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)67.50K sh
Reported value held$808.65K
Portfolio Weight0.53%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ACT CAPITAL MANAGEMENT, LLC's RGNX position evolved

ACT CAPITAL MANAGEMENT, LLC first disclosed a stake in RGNX in Q4 2025 at 82,500 shares (US$1.2M). Across 3 filings, ACT CAPITAL MANAGEMENT, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 67,500 shares valued at US$809K — an increase of 11,500 shares quarter over quarter.. Notable position changes include a 32% trim in Q1 2026 (shares rose 43% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 82.50K $1.19M New
Q1 2026 56.00K $469.28K Reduce
Q2 2026 67.50K $808.65K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGNX and 13F data

RGNX (REGENXBIO INC) is a Health Care company. 34 other funds we track also report a position in RGNX — the largest reported positions include Redmile Group, LLC (US$52.3M), 22NW, LP (US$5.9M), Pale Fire Capital SE (US$5.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGNX

All RGNX fund holders →

FAQ

How long has ACT CAPITAL MANAGEMENT, LLC held RGNX?

ACT CAPITAL MANAGEMENT, LLC has disclosed RGNX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is ACT CAPITAL MANAGEMENT, LLC's current position in RGNX?

As of Q2 2026, ACT CAPITAL MANAGEMENT, LLC holds 67.50K shares of RGNX (REGENXBIO INC), valued at $808.65K, representing 0.53% of its reported portfolio and ranking #31.

Has ACT CAPITAL MANAGEMENT, LLC been buying or selling RGNX?

In the latest 13F filing (Q2 2026), ACT CAPITAL MANAGEMENT, LLC increased its position in RGNX.

Which other funds hold RGNX?

Other major institutional holders of RGNX include Redmile Group, LLC, 22NW, LP, Pale Fire Capital SE, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.